CUR-N399

N/A

Report date: 2023/09/05 14:23:07
NME

Base Information

Drug NameCUR-N399
Drug Alias NameCUR-N399CUR-N-399
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-kinase beta inhibitors
TargetsPhosphatidylinositol 4-kinase beta
Therapy Area/IndicationsRhinovirus infectionPulmonary Disease, Chronic ObstructiveEnterovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCurovir AB
China Registration ClassN/A

Develop Information

Active CompaniesCurovir AB
Inactive CompaniesN/A
Active IndicationsRhinovirus infectionPulmonary Disease, Chronic ObstructiveEnterovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A